Therapies under investigation for Alagille syndrome would offer physicians the means to target defective areas in a more focused manner.
As we look over the evolution of medicine, we see we have gone from what can be described as crude experimentation in ancient times to more sophisticated ways of managing the signs and symptoms of a disease in the past century. The effort to dig deeper through the layers of a disease to reach its…
Three Lakes Foundation, Yale University, and the University of Pittsburgh are joining forces to speed up the search for treatments for pulmonary fibrosis.
There are a few things that physicians do their best to avoid when a patient is under their care. One of the most basic things to check, for example, is the patient’s allergy status to avoid needless drug reactions that can sometimes be life-threatening. Another thing that is always on a physician’s mind is the…
In Pompe disease, the mutational landscape and the amount of AAG activity determine the disease severity, tissue impairment, and age of onset.
Researchers issued updated recommendations for the treatment of acquired hemophilia A based on new evidence.
Cellular senescence contributes to the macromolecular damage and metabolic dysregulation seen in many diseases, including IPF.
We know the classical symptoms of LAL-D, but what does it have to do with bone health? We explore this question and more.
A review article reveals that lung and liver transplantation have favorable outcomes in AATD patients with end-stage lung and liver diseases.
We explore the role of genomic sequencing in diagnosing Alagille syndrome and some of the dilemmas of genetic testing for this disease.
Next post in IPF Features